Literature DB >> 25959669

Reply: To PMID 25174863.

Anne E Dixon1, Mario Castro2, Rubin I Cohen3, Lynn B Gerald4, Janet T Holbrook5, Charles G Irvin6, Shyam Mohapatra7, Stephen P Peters8, Sobharani Rayapudi9, Elizabeth A Sugar10, Robert A Wise9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25959669      PMCID： PMC5606190          DOI： 10.1016/j.jaci.2015.04.003

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  5 in total

1.  Nasal endoscopy to characterize sinonasal disease.

Authors:  Brian Lipworth
Journal:  J Allergy Clin Immunol       Date:  2015-05-08       Impact factor: 10.793

2.  Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control.

Authors:  Robert A Nathan; Steven W Yancey; Kelli Waitkus-Edwards; Barbara A Prillaman; John L Stauffer; Edward Philpot; Paul M Dorinsky; Harold S Nelson
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

3.  Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis.

Authors:  Rohit K Katial; John J Oppenheimer; Nancy K Ostrom; Giselle S Mosnaim; Steven W Yancey; Kelli R Waitkus-Edwards; Barbara A Prillaman; Hector G Ortega
Journal:  Allergy Asthma Proc       Date:  2010 Jan-Feb       Impact factor: 2.587

4.  Efficacy of nasal mometasone for the treatment of chronic sinonasal disease in patients with inadequately controlled asthma.

Authors:  Anne E Dixon; Mario Castro; Rubin I Cohen; Lynn B Gerald; Janet T Holbrook; Charles G Irvin; Shyam Mohapatra; Stephen P Peters; Sobharani Rayapudi; Elizabeth A Sugar; Robert A Wise
Journal:  J Allergy Clin Immunol       Date:  2014-08-28       Impact factor: 10.793

5.  Criteria to screen for chronic sinonasal disease.

Authors:  Anne E Dixon; Elizabeth A Sugar; S James Zinreich; Raymond G Slavin; Jonathan Corren; Robert M Naclerio; Masaru Ishii; Rubin I Cohen; Ellen D Brown; Robert A Wise; Charles G Irvin
Journal:  Chest       Date:  2009-07-06       Impact factor: 9.410
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.